0001209191-20-011965.txt : 20200224
0001209191-20-011965.hdr.sgml : 20200224
20200224162514
ACCESSION NUMBER: 0001209191-20-011965
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200220
FILED AS OF DATE: 20200224
DATE AS OF CHANGE: 20200224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BEDOYA JOSE H
CENTRAL INDEX KEY: 0001207430
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23837
FILM NUMBER: 20644661
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SURMODICS INC
CENTRAL INDEX KEY: 0000924717
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411356149
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 9924 W 74TH ST
CITY: EDEN PRAIRIE
STATE: MN
ZIP: 55344
BUSINESS PHONE: 9525007000
MAIL ADDRESS:
STREET 1: 9924 WEST 74TH ST
CITY: EDEN PRAIRIE
STATE: MN
ZIP: 55344
FORMER COMPANY:
FORMER CONFORMED NAME: BSI CORP
DATE OF NAME CHANGE: 19970506
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-20
0
0000924717
SURMODICS INC
SRDX
0001207430
BEDOYA JOSE H
604 10TH STREET
BOULDER
CO
80302
1
0
0
0
Common Stock
2020-02-20
4
S
0
1821
37.5147
D
21750
D
Reflects the weighted average price of 1,821 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 20, 2020 with sale prices ranging from $37.51 to $37.55 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The amount beneficially owned includes 10,995 restricted stock units (RSUs) that vest on service-based vesting dates and 8,430 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
/s/ John Manders, on behalf of Jose H. Bedoya
2020-02-24
EX-24.4_897386
2
poa.txt
POA DOCUMENT
EXHIBIT 24
POWER OF ATTORNEY
I, Jose H. Bedoya, hereby authorize and designate each of
John Manders, Timothy Arens, Nicole J. Leimer, and Amra Hoso signing
singly, as my true and lawful attorney-in-fact to:
(1) execute for and on my behalf, in my capacity as an officer and/or
director of Surmodics, Inc., a Minnesota corporation (the "Company"), the
Forms 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act
of 1934 (the "Exchange Act") and the rules and regulations promulgated
thereunder;
(2) do and perform any and all acts for and on my behalf which may be
necessary or desirable to complete and execute any such Forms 4 or 5 and
timely file such form with the Securities and Exchange Commission, any stock
exchange or similar authority, and the NASDAQ Stock Market; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be to my
benefit, in my best interest, or legally required of me, it being understood
that the statements executed by such attorney-in-fact on my behalf pursuant to
this Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney-in-fact's
discretion.
I hereby further grant to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and
powers herein granted, as fully to all intents and purposes as I might or
could do if personally present, with full power of substitutes or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted. I hereby acknowledge that the foregoing attorneys-in-fact, in
serving in such capacity at my request, are not assuming, nor is the Company
assuming, any of my responsibilities to comply with Section 16 of the Exchange
Act.
This Power of Attorney shall remain in full force and effect until
I am no longer required to file Forms 4 and 5 with respect to my holdings of
and transactions in securities issued by the Company, unless earlier revoked
by me in a signed writing delivered to the foregoing attorneys-in-fact.
Notwithstanding the foregoing, if any such attorney-in-fact hereafter ceases
to be either a partner or employee of Faegre Baker Daniels LLP, or an employee
of the Company, this Power of Attorney shall be automatically revoked solely
as to such individual, immediately upon such cessation, without any further
action on my part.
I hereby revoke all previous Powers of Attorney that have been
granted by me in connection with my reporting obligations under Section 16 of
the Exchange Act with respect to my holdings of and transactions in securities
issued by the Company.
IN WITNESS WHEREOF, I have caused this Power of Attorney to be duly
executed as of this 12th day of February, 2020.
/s/ Jose H. Bedoya